Search Results 571-580 of 17867 for Coagulation

  1. Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    Coagulation parameters: International normalized ratio (INR) \>2, prolongation of prothrombin time (PT) and activated partial thromboplastin time (aPTT) by ...

  2. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

    Patients on a stable dose of anti-coagulation therapy will be allowed to participate if they have no signs of bleeding or clotting and the INR/PT and PTT ...

  3. A Phase 1b/2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma - Mayo Clinic

    History of clinically significant coagulation or platelet disorder in the past 12 months; Currently receiving anticoagulation treatment; Incomplete healing ...

  4. Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    Coagulation parameters: International normalized ratio (INR) >2, prolongation of prothrombin time (PT) and activated partial thromboplastin time (aPTT) by ...

  5. A Study to Investigate the Effectiveness of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis - Mayo Clinic

    ... coagulation, immunological, endocrine/metabolic, or other medical disorder that, in the opinion of the investigator, might confound study results, pose ...

  6. Publications - Nadine H. Abdallah, M.D. - Mayo Clinic

    Coagulation Abnormalities in Light Chain Amyloidosis. Mayo Clin Proc. 2021 Feb; 96 (2):377-387. View PubMed; Kanj A, Samhouri B, Abdallah N, Chehab O, Baqir M ...

  7. Publications - Mark D. Rollins, M.D., Ph.D. - Mayo Clinic

    Thromboemboli, acute right heart failure and disseminated intravascular coagulation after intraoperative application of a topical hemostatic matrix. Anesth ...

  8. A Study to Evaluate the Effectiveness and Safety of Vedolizumab to Treat Chronic Pouchitis - Mayo Clinic

    Has any unstable or uncontrolled cardiovascular, pulmonary, hepatic, renal, gastrointestinal (GI), genitourinary, hematological, coagulation, immunological ...

  9. Lenalidomide or Observation in Treating Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    ... coagulation as prophylaxis if they are not currently on full-dose anticoagulation; Patients should not have New York Heart Association classification III or ...

  10. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

    Coagulation test: at time of screening, international normalized ratio (INR) ≤1.5, and the activated partial thromboplastin time (APTT) ≤ 1.5× ULN.